This legislation amends the Public Health Service Act to remove legal liability protections that currently shield vaccine manufacturers from civil lawsuits. The bill eliminates provisions of the National Vaccine Injury Compensation Program that restrict individuals' ability to sue manufacturers and administrators directly in state or federal courts. It also removes time limitations on filing compensation petitions and explicitly excludes COVID-19 vaccines from liability protections. Additionally, the bill applies these changes retroactively, allowing claims that were previously barred by statute of limitations to proceed. The effect is to restore individual citizens' right to pursue legal remedies through the court system for alleged vaccine-related injuries or deaths.
Why It Matters to MAHA
This bill directly advances MAHA's core commitment to health freedom and patient autonomy by restoring individuals' fundamental right to seek justice through the courts when they suffer harm. Currently, liability shields prevent patients from holding manufacturers accountable, creating a system where companies face minimal legal consequence for injuries and deaths. Removing these protections increases transparency and accountability in the vaccine industry, forcing manufacturers to prioritize safety standards knowing they can be held legally responsible. The bill also restores patient agency by eliminating artificial time restrictions and mandatory compensation program procedures that limited injured individuals' options. By returning power to patients and the courts rather than protecting corporate interests, this legislation embodies MAHA's belief that individuals should control decisions about their health and have recourse when harmed.